Genfit (Genfit) Price-to-Tangible-Book : 10.79 (As of May. 25, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Genfit Price-to-Tangible-Book?

As of today (2024-05-25), Genfit's share price is $4.53. Genfit's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.42. Hence, Genfit's Price to Tangible Book Ratio of today is 10.79.

The historical rank and industry rank for Genfit's Price-to-Tangible-Book or its related term are showing as below:

GNFT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.81 Med: 8.25 Max: 26.86
Current: 10.53

During the past 13 years, Genfit's highest Price to Tangible Book Ratio was 26.86. The lowest was 1.81. And the median was 8.25.

GNFT's Price-to-Tangible-Book is ranked worse than
88.96% of 1223 companies
in the Biotechnology industry
Industry Median: 2.78 vs GNFT: 10.53

A closely related ratio is called PB Ratio. As of today, Genfit's share price is $4.53. Genfit's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.49. Hence, Genfit's P/B Ratio of today is 3.05.

Genfit Price-to-Tangible-Book Historical Data

The historical data trend for Genfit's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit Price-to-Tangible-Book Chart

Genfit Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.37

1.85

4.08

9.17

Genfit Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	4.08	5.75	-	9.17

Competitive Comparison of Genfit's Price-to-Tangible-Book

For the Biotechnology subindustry, Genfit's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Genfit's Price-to-Tangible-Book falls into.

Genfit Price-to-Tangible-Book Calculation

Genfit's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	4.53	/	0.42
	=	10.79

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Genfit Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Genfit's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Genfit (Genfit) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

GNFTF:USA 0QT6:UK GNFT:France XUPB:Germany

Address

Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120

Website

https://www.genfit.com

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.